Application of jak-1 signal pathway inhibitor in preparation of medicine for treating brain injury
A technology of JAK-1 and signaling pathways, applied in the field of biomedicine, can solve problems such as secondary damage and damage, achieve the effect of reducing the degree of neuron degeneration, reducing brain edema, and improving nerve function damage
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0043] Sixty-six 6-8-week-old male C57 / BL6J mice (20-25g) with basically the same body weight were randomly divided into three groups, 22 in each group, respectively: control group (Sha group), Vehicle treatment craniocerebral injury group ( Vehicle group), Ruxolitinib treatment craniocerebral injury group (RUXO group).
[0044] The mice in the control group were fed normally without any treatment. The modeling steps of Vehicle group and RUXO group are as follows:
[0045]The mice in each group were fixed with a stereotaxic instrument, the mouse scalp was cut to expose the skull, the coronal suture and the sagittal suture tangent line were on both sides, and a circular hole with a diameter of 4mm was drilled in the left hemisphere to expose the brain tissue. Then use the air pressure impact quantitative cortical striker to strike to establish a craniocerebral injury model. The Vehicle group was intraperitoneally injected with 0.01% DMSO (0.2 mL) within 30 minutes after crani...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com